CD24Fc to DAMPen GVHD

Agents historically used to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplant (HCT) have typically targeted T cells.In this issue of Blood, Magenau et al 1 show that agents targeting antigenpresenting cells can also help prevent GVHD.